Logo image of ADGM

ADAGIO MEDICAL HOLDINGS INC (ADGM) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ADGM - US00534B1008 - Common Stock

1.08 USD
+0.15 (+16.13%)
Last: 1/23/2026, 8:00:00 PM
1.05 USD
-0.03 (-2.78%)
After Hours: 1/23/2026, 8:00:00 PM
Fundamental Rating

1

Overall ADGM gets a fundamental rating of 1 out of 10. We evaluated ADGM against 184 industry peers in the Health Care Equipment & Supplies industry. ADGM has a bad profitability rating. Also its financial health evaluation is rather negative. ADGM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year ADGM has reported negative net income.
  • ADGM had a negative operating cash flow in the past year.
  • ADGM had negative earnings in 4 of the past 5 years.
  • ADGM had a negative operating cash flow in each of the past 5 years.
ADGM Yearly Net Income VS EBIT VS OCF VS FCFADGM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

  • ADGM's Return On Assets of -250.89% is on the low side compared to the rest of the industry. ADGM is outperformed by 91.85% of its industry peers.
Industry RankSector Rank
ROA -250.89%
ROE N/A
ROIC N/A
ROA(3y)-230.1%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ADGM Yearly ROA, ROE, ROICADGM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

  • ADGM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADGM Yearly Profit, Operating, Gross MarginsADGM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -2K -4K -6K -8K -10K

0

2. Health

2.1 Basic Checks

  • ADGM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ADGM has been increased compared to 1 year ago.
  • Compared to 1 year ago, ADGM has an improved debt to assets ratio.
ADGM Yearly Shares OutstandingADGM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
ADGM Yearly Total Debt VS Total AssetsADGM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -6.53, we must say that ADGM is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -6.53, ADGM is not doing good in the industry: 72.28% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.53
ROIC/WACCN/A
WACC7.2%
ADGM Yearly LT Debt VS Equity VS FCFADGM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • ADGM has a Current Ratio of 0.84. This is a bad value and indicates that ADGM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ADGM's Current ratio of 0.84 is on the low side compared to the rest of the industry. ADGM is outperformed by 89.13% of its industry peers.
  • ADGM has a Quick Ratio of 0.84. This is a bad value and indicates that ADGM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ADGM has a Quick ratio of 0.68. This is amonst the worse of the industry: ADGM underperforms 86.96% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.68
ADGM Yearly Current Assets VS Current LiabilitesADGM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

3

3. Growth

3.1 Past

  • ADGM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -229.28%.
  • ADGM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -68.79%.
EPS 1Y (TTM)-229.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.56%
Revenue 1Y (TTM)-68.79%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.15% on average over the next years. This is quite good.
  • Based on estimates for the next years, ADGM will show a very strong growth in Revenue. The Revenue will grow by 80.03% on average per year.
EPS Next Y65.5%
EPS Next 2Y34%
EPS Next 3Y21.17%
EPS Next 5Y15.15%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y45.02%
Revenue Next 5Y80.03%

3.3 Evolution

ADGM Yearly Revenue VS EstimatesADGM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2027 2028 2M 4M 6M
ADGM Yearly EPS VS EstimatesADGM Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 -0.5 -1 -1.5

1

4. Valuation

4.1 Price/Earnings Ratio

  • ADGM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ADGM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADGM Price Earnings VS Forward Price EarningsADGM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADGM Per share dataADGM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ADGM's earnings are expected to grow with 21.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34%
EPS Next 3Y21.17%

0

5. Dividend

5.1 Amount

  • ADGM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ADAGIO MEDICAL HOLDINGS INC / ADGM FAQ

What is the ChartMill fundamental rating of ADAGIO MEDICAL HOLDINGS INC (ADGM) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ADGM.


What is the valuation status for ADGM stock?

ChartMill assigns a valuation rating of 1 / 10 to ADAGIO MEDICAL HOLDINGS INC (ADGM). This can be considered as Overvalued.


What is the profitability of ADGM stock?

ADAGIO MEDICAL HOLDINGS INC (ADGM) has a profitability rating of 0 / 10.


What is the expected EPS growth for ADAGIO MEDICAL HOLDINGS INC (ADGM) stock?

The Earnings per Share (EPS) of ADAGIO MEDICAL HOLDINGS INC (ADGM) is expected to grow by 65.5% in the next year.